|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000198183 |
Summary for BPIFA1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000198183 | Gene symbol | BPIFA1 |
| Gene name | BPI fold containing family A member 1 | |
| HGNC | 15749 | |
| Entrez ID | 51297 | |
| Gene type | protein_coding | |
| Synonyms | BPIFA1|LUNX|bA49G10.5|SPLUNC1 | |
| UniProtAcc | Q9NP55 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for BPIFA1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BPIFA1 | 1.64e+01 | -6.95e+00 | 1.82e+00 | -3.82e+00 | 1.35e-04 | 2.58e-03 | BRCA |
| BPIFA1 | 1.20e+04 | 1.11e+00 | 2.70e-01 | 4.12e+00 | 3.73e-05 | 9.36e-04 | LUAD |
| BPIFA1 | 3.92e+00 | -1.91e+00 | 6.06e-01 | -3.16e+00 | 1.58e-03 | 9.59e-03 | LIHC |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BPIFA1 | 2.08e+01 | 5.91e+00 | 1.51e+00 | 3.91e+00 | 9.33e-05 | 4.19e-04 | BLCA |
| BPIFA1 | 1.31e+01 | 2.88e+00 | 8.85e-01 | 3.26e+00 | 1.12e-03 | 3.11e-03 | STAD |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BPIFA1 | 6.42e+00 | 4.81e+00 | 1.33e+00 | 3.61e+00 | 3.08e-04 | 8.85e-04 | LIHC |
| BPIFA1 | 1.52e+01 | 3.65e+00 | 5.89e-01 | 6.19e+00 | 5.97e-10 | 1.27e-09 | BRCA |
Top |
Sex-biased somatic mutation for BPIFA1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for BPIFA1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| ACC | cg01910481 | chr20:33236262 | CGI:chr20:33401338-33401612 | promoter,gene body | 8.01e-01 | 6.60e-01 | 2.25e+00 | 2.45e-02 | 3.84e-02 | 1.41e-01 |
| KICH | cg10655041 | chr20:33236091 | CGI:chr20:33401338-33401612 | promoter,gene body | 8.58e-01 | 7.53e-01 | 2.56e+00 | 1.05e-02 | 2.79e-02 | 1.05e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg11846968 | chr20:33235739 | CGI:chr20:33401338-33401612 | promoter | 7.01e-01 | 8.30e-01 | -2.62e+00 | 8.84e-03 | 1.20e-02 | -1.30e-01 |
| LUAD | cg19059861 | chr20:33235955 | CGI:chr20:33401338-33401612 | promoter | 4.72e-01 | 5.76e-01 | -3.03e+00 | 2.48e-03 | 4.17e-03 | -1.04e-01 |
| HNSC | cg17884201 | chr20:33235566 | CGI:chr20:33401338-33401612 | promoter | 7.97e-01 | 9.23e-01 | -2.51e+00 | 1.22e-02 | 1.52e-02 | -1.25e-01 |
| LUSC | cg20893898 | chr20:33235071 | CGI:chr20:33401338-33401612 | promoter | 6.63e-01 | 8.98e-01 | -4.44e+00 | 8.92e-06 | 5.26e-04 | -2.35e-01 |
| LUSC | cg17884201 | chr20:33235566 | CGI:chr20:33401338-33401612 | promoter | 7.53e-01 | 9.38e-01 | -3.20e+00 | 1.36e-03 | 3.20e-03 | -1.85e-01 |
| LUSC | cg11846968 | chr20:33235739 | CGI:chr20:33401338-33401612 | promoter | 5.23e-01 | 8.70e-01 | -4.28e+00 | 1.90e-05 | 5.26e-04 | -3.47e-01 |
| LUSC | cg19059861 | chr20:33235955 | CGI:chr20:33401338-33401612 | promoter | 3.19e-01 | 5.52e-01 | -4.26e+00 | 2.02e-05 | 5.26e-04 | -2.32e-01 |
| LUSC | cg10655041 | chr20:33236091 | CGI:chr20:33401338-33401612 | promoter,gene body | 4.50e-01 | 7.32e-01 | -4.03e+00 | 5.64e-05 | 5.75e-04 | -2.83e-01 |
| LUSC | cg01910481 | chr20:33236262 | CGI:chr20:33401338-33401612 | promoter,gene body | 6.82e-01 | 9.57e-01 | -4.18e+00 | 2.94e-05 | 5.26e-04 | -2.76e-01 |
| COAD | cg19059861 | chr20:33235955 | CGI:chr20:33401338-33401612 | promoter | 2.60e-01 | 3.76e-01 | -4.41e+00 | 1.05e-05 | 6.10e-05 | -1.16e-01 |
| LIHC | cg20893898 | chr20:33235071 | CGI:chr20:33401338-33401612 | promoter | 5.61e-01 | 8.05e-01 | -5.37e+00 | 7.95e-08 | 4.35e-07 | -2.44e-01 |
| LIHC | cg17884201 | chr20:33235566 | CGI:chr20:33401338-33401612 | promoter | 5.21e-01 | 8.72e-01 | -4.72e+00 | 2.34e-06 | 7.73e-06 | -3.51e-01 |
| LIHC | cg19059861 | chr20:33235955 | CGI:chr20:33401338-33401612 | promoter | 2.40e-01 | 4.24e-01 | -7.04e+00 | 1.95e-12 | 2.15e-10 | -1.83e-01 |
| ESCA | cg20893898 | chr20:33235071 | CGI:chr20:33401338-33401612 | promoter | 6.59e-01 | 7.73e-01 | -2.09e+00 | 3.62e-02 | 4.56e-02 | -1.14e-01 |
| ESCA | cg17884201 | chr20:33235566 | CGI:chr20:33401338-33401612 | promoter | 7.65e-01 | 9.28e-01 | -2.32e+00 | 2.02e-02 | 4.04e-02 | -1.63e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg11846968 | chr20:33235739 | CGI:chr20:33401338-33401612 | promoter | 5.47e-01 | 8.02e-01 | -1.24e+01 | 3.67e-35 | 1.11e-33 | -2.55e-01 |
| BRCA | cg19059861 | chr20:33235955 | CGI:chr20:33401338-33401612 | promoter | 3.08e-01 | 4.78e-01 | -1.33e+01 | 4.21e-40 | 3.40e-38 | -1.70e-01 |
| BRCA | cg10655041 | chr20:33236091 | CGI:chr20:33401338-33401612 | promoter,gene body | 4.93e-01 | 7.14e-01 | -1.17e+01 | 1.10e-31 | 1.98e-30 | -2.21e-01 |
Top |
Exon skipping events with PSI in TCGA for BPIFA1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for BPIFA1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for BPIFA1 |
| TFs related to BPIFA1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| MESO | FOXA1 | BPIFA1 | 4.86e+00 | 9.96e-01 | 2.60e+00 | 2.48e-04 | Male-biased |
| MESO | FOXA3 | BPIFA1 | 4.93e+00 | 9.96e-01 | 2.78e+00 | 3.72e-04 | Male-biased |
| MESO | HESX1 | BPIFA1 | 5.63e+00 | 9.94e-01 | 4.19e+00 | 4.81e-03 | Male-biased |
| MESO | LHX9 | BPIFA1 | 5.60e+00 | 9.94e-01 | 4.12e+00 | 4.32e-03 | Male-biased |
| MESO | POU3F1 | BPIFA1 | 6.26e+00 | 9.85e-01 | 5.15e+00 | 1.42e-02 | Male-biased |
| MESO | TBP | BPIFA1 | 5.05e+00 | 9.94e-01 | 3.50e+00 | 3.34e-03 | Male-biased |
| MESO | YY1 | BPIFA1 | 5.04e+00 | 9.90e-01 | 3.70e+00 | 6.63e-03 | Male-biased |
| MESO | ZFP69 | BPIFA1 | 4.40e+00 | 9.81e-01 | 3.23e+00 | 1.11e-02 | Male-biased |
| MESO | ZKSCAN2 | BPIFA1 | 5.02e+00 | 9.96e-01 | 3.15e+00 | 1.06e-03 | Male-biased |
| MESO | ZNF184 | BPIFA1 | 4.39e+00 | 9.80e-01 | 3.25e+00 | 1.20e-02 | Male-biased |
| MESO | ZNF620 | BPIFA1 | 4.77e+00 | 9.91e-01 | 3.31e+00 | 4.49e-03 | Male-biased |
| MESO | ZNF74 | BPIFA1 | 5.11e+00 | 9.90e-01 | 3.80e+00 | 7.23e-03 | Male-biased |
| MESO | ZSCAN16 | BPIFA1 | 4.99e+00 | 9.82e-01 | 3.89e+00 | 1.47e-02 | Male-biased |
| MESO | ZSCAN4 | BPIFA1 | 4.49e+00 | 9.82e-01 | 3.31e+00 | 1.10e-02 | Male-biased |
| PAAD | FOXA1 | BPIFA1 | 2.95e+00 | 6.36e-04 | 4.28e+00 | 9.91e-01 | Female-biased |
| PAAD | FOXA3 | BPIFA1 | 3.09e+00 | 9.37e-04 | 4.34e+00 | 9.91e-01 | Female-biased |
| PAAD | HESX1 | BPIFA1 | 4.37e+00 | 1.36e-02 | 5.11e+00 | 9.84e-01 | Female-biased |
| PAAD | LHX9 | BPIFA1 | 4.32e+00 | 9.20e-03 | 5.14e+00 | 9.88e-01 | Female-biased |
| PAAD | TBP | BPIFA1 | 3.74e+00 | 6.90e-03 | 4.62e+00 | 9.88e-01 | Female-biased |
| PAAD | ZFP69 | BPIFA1 | 3.29e+00 | 8.03e-03 | 4.13e+00 | 9.81e-01 | Female-biased |
| PAAD | ZKSCAN2 | BPIFA1 | 3.38e+00 | 2.18e-03 | 4.48e+00 | 9.92e-01 | Female-biased |
| PAAD | ZNF620 | BPIFA1 | 3.53e+00 | 7.11e-03 | 4.40e+00 | 9.86e-01 | Female-biased |
| PAAD | ZNF74 | BPIFA1 | 3.96e+00 | 1.08e-02 | 4.75e+00 | 9.85e-01 | Female-biased |
| THYM | FOXA1 | BPIFA1 | 4.51e+00 | 9.92e-01 | 2.32e+00 | 2.39e-05 | Male-biased |
| THYM | FOXA3 | BPIFA1 | 4.64e+00 | 9.94e-01 | 2.47e+00 | 2.63e-05 | Male-biased |
| THYM | HESX1 | BPIFA1 | 5.43e+00 | 9.98e-01 | 3.94e+00 | 3.67e-04 | Male-biased |
| THYM | HOXA5 | BPIFA1 | 5.39e+00 | 9.95e-01 | 4.38e+00 | 2.62e-03 | Male-biased |
| THYM | KLF17 | BPIFA1 | 3.06e+00 | 1.02e-03 | 4.31e+00 | 9.88e-01 | Female-biased |
| THYM | LHX9 | BPIFA1 | 5.46e+00 | 9.98e-01 | 3.91e+00 | 2.98e-04 | Male-biased |
| THYM | LYL1 | BPIFA1 | 3.04e+00 | 1.79e-03 | 4.15e+00 | 9.85e-01 | Female-biased |
| THYM | POU3F1 | BPIFA1 | 6.24e+00 | 9.99e-01 | 4.93e+00 | 7.80e-04 | Male-biased |
| THYM | RUNX2 | BPIFA1 | 4.63e+00 | 9.87e-01 | 3.87e+00 | 6.98e-03 | Male-biased |
| THYM | TBP | BPIFA1 | 4.88e+00 | 9.96e-01 | 3.30e+00 | 2.53e-04 | Male-biased |
| THYM | TCF3 | BPIFA1 | 3.03e+00 | 4.83e-04 | 4.47e+00 | 9.91e-01 | Female-biased |
| THYM | TEAD2 | BPIFA1 | 5.24e+00 | 9.91e-01 | 4.45e+00 | 6.42e-03 | Male-biased |
| THYM | YY1 | BPIFA1 | 4.83e+00 | 9.94e-01 | 3.65e+00 | 1.28e-03 | Male-biased |
| THYM | ZFP69 | BPIFA1 | 4.23e+00 | 9.87e-01 | 3.15e+00 | 1.84e-03 | Male-biased |
| THYM | ZIC3 | BPIFA1 | 3.56e+00 | 2.35e-03 | 4.61e+00 | 9.91e-01 | Female-biased |
| THYM | ZIC4 | BPIFA1 | 3.51e+00 | 2.40e-03 | 4.55e+00 | 9.90e-01 | Female-biased |
| THYM | ZIC5 | BPIFA1 | 3.57e+00 | 2.79e-03 | 4.58e+00 | 9.90e-01 | Female-biased |
| THYM | ZKSCAN2 | BPIFA1 | 4.58e+00 | 9.93e-01 | 2.91e+00 | 1.70e-04 | Male-biased |
| THYM | ZNF17 | BPIFA1 | 3.23e+00 | 1.36e-03 | 4.41e+00 | 9.89e-01 | Female-biased |
| THYM | ZNF184 | BPIFA1 | 4.28e+00 | 9.84e-01 | 3.45e+00 | 4.98e-03 | Male-biased |
| THYM | ZNF415 | BPIFA1 | 2.89e+00 | 4.62e-04 | 4.34e+00 | 9.89e-01 | Female-biased |
| THYM | ZNF530 | BPIFA1 | 2.58e+00 | 3.25e-04 | 4.11e+00 | 9.85e-01 | Female-biased |
| THYM | ZNF573 | BPIFA1 | 3.49e+00 | 2.14e-03 | 4.56e+00 | 9.90e-01 | Female-biased |
| THYM | ZNF594 | BPIFA1 | 3.31e+00 | 5.76e-03 | 4.13e+00 | 9.80e-01 | Female-biased |
| THYM | ZNF620 | BPIFA1 | 4.41e+00 | 9.91e-01 | 3.00e+00 | 4.88e-04 | Male-biased |
| THYM | ZNF74 | BPIFA1 | 4.95e+00 | 9.95e-01 | 3.68e+00 | 8.70e-04 | Male-biased |
| THYM | ZNF768 | BPIFA1 | 2.71e+00 | 5.75e-04 | 4.10e+00 | 9.85e-01 | Female-biased |
| THYM | ZNF778 | BPIFA1 | 3.88e+00 | 5.05e-03 | 4.74e+00 | 9.89e-01 | Female-biased |
| THYM | ZSCAN16 | BPIFA1 | 4.78e+00 | 9.88e-01 | 4.02e+00 | 7.03e-03 | Male-biased |
| THYM | ZSCAN30 | BPIFA1 | 2.55e+00 | 2.08e-04 | 4.20e+00 | 9.87e-01 | Female-biased |
| THYM | ZSCAN4 | BPIFA1 | 4.43e+00 | 9.88e-01 | 3.50e+00 | 3.44e-03 | Male-biased |
| BPIFA1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for BPIFA1 |
| RBPs related to ES in BPIFA1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BPIFA1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1547159 | chr20:39845696:G:T | - | 0.0897688740578552 | 0.0244050829463711 | HNSC | Female-baised eQTL |
| rs13045202 | chr20:39839369:G:A | - | 0.0871897413352755 | 0.0312943494139436 | HNSC | Female-baised eQTL |
| rs8121497 | chr20:39838790:T:C | - | 0.0847783328900982 | 0.0395320655044451 | HNSC | Female-baised eQTL |
| rs62211642 | chr20:25095671:T:C | - | 0.189633814958074 | 0.00162925151975233 | BLCA | Female-baised eQTL |
| rs4330176 | chr20:25093285:G:A | - | 0.172037353397328 | 0.00521580926550926 | BLCA | Female-baised eQTL |
| rs11904867 | chr20:25095696:G:A | - | 0.157353196975894 | 0.0129785205172867 | BLCA | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs6028574 | chr20:39648298:G:A | - | 0.0330192838298161 | 0.0271972679734173 | HNSC | Male-baised eQTL |
| rs73104854 | chr20:23942910:C:T | - | 0.0530135362654169 | 0.00851609193058877 | BLCA | Male-baised eQTL |
| rs6076170 | chr20:23973194:A:G | - | 0.0444506575596581 | 0.0304205535832821 | BLCA | Male-baised eQTL |
| rs73101504 | chr20:37525419:C:T | - | 0.0567911716139867 | 0.00943433341378079 | LUAD | Male-baised eQTL |
| rs2425349 | chr20:37508358:T:C | - | 0.0564252425927129 | 0.00969285637324146 | LUAD | Male-baised eQTL |
| rs2425352 | chr20:37513430:T:A | - | 0.0559397364003305 | 0.0106788844304746 | LUAD | Male-baised eQTL |
| rs2425353 | chr20:37513808:C:T | - | 0.0559397364003305 | 0.0106788844304746 | LUAD | Male-baised eQTL |
| rs2425354 | chr20:37513879:C:T | - | 0.0559397364003305 | 0.0106788844304746 | LUAD | Male-baised eQTL |
| rs2425355 | chr20:37514319:G:A | - | 0.0559397364003305 | 0.0106788844304746 | LUAD | Male-baised eQTL |
| rs11696280 | chr20:37551632:G:A | - | 0.0555189871685043 | 0.0116746002789567 | LUAD | Male-baised eQTL |
| rs6019103 | chr20:37524958:A:C | - | -0.0544386847587148 | 0.0141233275361573 | LUAD | Male-baised eQTL |
| rs6090836 | chr20:37525602:T:C | - | -0.0544386847587148 | 0.0141233275361573 | LUAD | Male-baised eQTL |
| rs10854179 | chr20:37527967:A:C | - | -0.0544386847587148 | 0.0141233275361573 | LUAD | Male-baised eQTL |
| rs6019062 | chr20:37520583:T:C | - | -0.0536686365403855 | 0.0156916700681054 | LUAD | Male-baised eQTL |
| rs6063269 | chr20:37536239:G:A | - | 0.0533436057537393 | 0.0167291879092272 | LUAD | Male-baised eQTL |
| rs2425348 | chr20:37505713:G:C | - | 0.053620633392908 | 0.0175314958339783 | LUAD | Male-baised eQTL |
| rs6019159 | chr20:37529088:A:C | - | 0.0528331578214634 | 0.0189208052704503 | LUAD | Male-baised eQTL |
| rs2024794 | chr20:37541595:T:C | - | -0.0512623531440927 | 0.0234358906073382 | LUAD | Male-baised eQTL |
| rs4810777 | chr20:37511248:T:C | - | -0.0503677911668206 | 0.0300824703701834 | LUAD | Male-baised eQTL |
| rs4810805 | chr20:37536191:G:T | - | -0.0500201798849422 | 0.0301950982206327 | LUAD | Male-baised eQTL |
| rs910596 | chr20:37544147:C:T | - | -0.0482044615511045 | 0.0446681007021324 | LUAD | Male-baised eQTL |
| rs910595 | chr20:37544277:A:C | - | -0.0482044615511045 | 0.0446681007021324 | LUAD | Male-baised eQTL |
| rs910594 | chr20:37544324:C:A | - | -0.0482044615511045 | 0.0446681007021324 | LUAD | Male-baised eQTL |
| rs910593 | chr20:37544395:C:T | - | -0.0482044615511045 | 0.0446681007021324 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000198183 |
| CpG Site: cg10655041 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.315021357632005 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg10655041 | chr20:33236091 | gene,promoter | -0.315021357632005 | 2.85176291673023e-06 | -0.37856540728479593 | 5.212864231380924e-09 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of BPIFA1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000198183 | BPIFA1 | C0015923 | Fetal Alcohol Syndrome | 1 | CTD_human |
| ENSG00000198183 | BPIFA1 | C0814154 | Alcohol Related Neurodevelopmental Disorder | 1 | CTD_human |
| ENSG00000198183 | BPIFA1 | C2985290 | Fetal Alcohol Spectrum Disorders | 1 | CTD_human |
| ENSG00000198183 | BPIFA1 | C3146244 | Alcohol Related Birth Defect | 1 | CTD_human |
| ENSG00000198183 | BPIFA1 | C3661483 | Partial Fetal Alcohol Syndrome | 1 | CTD_human |
